This is because GLP-1 medications appetite-suppressing hormonal effects reverse within weeks of stopping
Proglucagon , a 160-residue peptide produced by the pancreas -cells and the small intestines K and L cells , undergoes selective posttranslational modifications to produce these essential incretin hormones
The Phase 2 obesity trial enrolled adults who were living with obesity or overweight (generally a BMI of 27 or higher)
EMA Decision P/0336/2024 Paediatric Investigation Plan for retatrutide
PubMed, Martchenko, Alexandre, and Patricia Lee Brubaker
These prolonged periods of high cortisol levels put your body into a seemingly never-ending fight or flight response, which has been linked to weight gain and visceral fat storage, and decreases in GLP-1